Development Level

Tbio 10 | 10,625
Tdark 1 | 7,003

Disease

Endometriosis 7 | 535
colon cancer 7 | 1,475
intraductal papillary-mucinous adenoma (IPMA) 7 | 2,956
intraductal papillary-mucinous carcinoma (IPMC) 7 | 2,988
intraductal papillary-mucinous neoplasm (IPMN) 7 | 3,289
lung cancer 7 | 4,466
medulloblastoma, large-cell 7 | 6,234
non-small cell lung cancer 7 | 2,798
ovarian cancer 7 | 8,484
ulcerative colitis 7 | 2,087
acute quadriplegic myopathy 6 | 1,157
atypical teratoid/rhabdoid tumor 6 | 1,095
cystic fibrosis 6 | 1,665
malignant mesothelioma 6 | 3,162
osteosarcoma 6 | 7,933
pancreatic cancer 6 | 2,300
active Crohn's disease 5 | 918
lung adenocarcinoma 5 | 2,713
primary pancreatic ductal adenocarcinoma 5 | 1,271
psoriasis 5 | 6,685
adrenocortical carcinoma 4 | 1,427
sonic hedgehog group medulloblastoma 4 | 1,482
Bladder Neoplasm 3 | 109
Breast cancer 3 | 3,094
Down syndrome 3 | 548
breast carcinoma 3 | 1,614
glioblastoma 3 | 5,572
group 3 medulloblastoma 3 | 2,254
invasive ductal carcinoma 3 | 2,950
lung carcinoma 3 | 2,844
Cancer 2 | 2,346
Liver carcinoma 2 | 217
Neoplasm Invasiveness 2 | 127
cutaneous lupus erythematosus 2 | 1,056
facioscapulohumeral dystrophy 2 | 286
inflammatory breast cancer 2 | 404
interstitial cystitis 2 | 2,299
nephrosclerosis 2 | 329
primitive neuroectodermal tumor 2 | 3,031
Alzheimer's disease 1 | 644
Arsenic Poisoning 1 | 59
Cardiomegaly 1 | 66
Esophageal Neoplasms 1 | 67
Heart Diseases 1 | 42
Hepatitis, Chronic 1 | 22
Impulse control disorder 1 | 3
Inverted papilloma 1 | 8
Kidney Diseases 1 | 86
Lead Poisoning 1 | 6
Liver Cirrhosis, Experimental 1 | 108
Lymphatic Metastasis 1 | 14
Mammary Neoplasms 1 | 410
Mouth Neoplasms 1 | 42
Pick disease 1 | 1,893
Prostatic Intraepithelial Neoplasias 1 | 11
Prostatic Neoplasms 1 | 471
Seizures 1 | 95
Squamous cell carcinoma 1 | 94
Stomach Neoplasms 1 | 282
Wernicke-Korsakoff syndrome 1 | 8
adrenocortical adenoma 1 | 134
adult high grade glioma 1 | 2,148
astrocytic glioma 1 | 2,241
astrocytoma 1 | 1,493
atypical teratoid / rhabdoid tumor 1 | 4,369
dermatomyositis 1 | 933
diabetes mellitus 1 | 1,663
ductal carcinoma in situ 1 | 1,745
ependymoma 1 | 2,514
esophageal adenocarcinoma 1 | 737
head and neck cancer 1 | 270
hereditary spastic paraplegia 1 | 313
mucosa-associated lymphoid tissue lymphoma 1 | 480
non-small cell lung carcinoma 1 | 413
pancreatic ductal adenocarcinoma liver metastasis 1 | 1,795
pituitary cancer 1 | 1,972
spina bifida 1 | 1,064
subependymal giant cell astrocytoma 1 | 2,287
tuberculosis and treatment for 6 months 1 | 686

Tissue

Cardiovascular System 11 | 17,958
Digestive Tract 11 | 18,473
Endocrine System 11 | 18,512
Female tissues 11 | 18,647
Liver and Pancreas 11 | 18,136
Nervous System 11 | 18,561
Skin and soft tissues 11 | 18,115
Urinary Tract 11 | 18,444
Male tissues 10 | 17,969
Respiratory system 10 | 17,484
Blood and immune system 9 | 17,995

Target Family

Non-IDG 11 | 11,971

Reactome Pathway

Metallothioneins bind metals 11 | 11
Signal Transduction 2,516 | 2,516
Immune System 2,184 | 2,184
Metabolism 2,132 | 2,132
Gene Expression 1,755 | 1,755
Metabolism of proteins 1,545 | 1,545
Innate Immune System 1,376 | 1,376
Signaling by GPCR 1,330 | 1,330
Developmental Biology 1,029 | 1,029
GPCR downstream signaling 1,015 | 1,015
Post-translational protein mod... 1,005 | 1,005
Adaptive Immune System 939 | 939
Disease 856 | 856
Generic Transcription Pathway 852 | 852
Cytokine Signaling in Immune s... 804 | 804
Metabolism of lipids and lipop... 797 | 797
Vesicle-mediated transport 705 | 705
Hemostasis 669 | 669
Transmembrane transport of sma... 669 | 669
Membrane Trafficking 608 | 608
Cell Cycle 573 | 573
Axon guidance 542 | 542
Neutrophil degranulation 542 | 542
Signaling by Interleukins 501 | 501
Cell Cycle, Mitotic 471 | 471
Signalling by NGF 468 | 468
GPCR ligand binding 456 | 456
Gastrin-CREB signalling pathwa... 436 | 436
Class I MHC mediated antigen p... 431 | 431
Olfactory Signaling Pathway 430 | 430
Fc epsilon receptor (FCERI) si... 424 | 424
Cellular responses to stress 416 | 416
DAP12 interactions 410 | 410
Infectious disease 392 | 392
NGF signalling via TRKA from t... 379 | 379
Signaling by Rho GTPases 378 | 378
Signaling by PDGF 368 | 368
Diseases of signal transductio... 360 | 360
Signaling by EGFR 356 | 356
Transcriptional Regulation by ... 356 | 356
Metabolism of amino acids and ... 354 | 354
DAP12 signaling 347 | 347
Downstream signal transduction 344 | 344
Neuronal System 343 | 343
Organelle biogenesis and maint... 334 | 334
Signaling by VEGF 330 | 330
Signaling by SCF-KIT 328 | 328
Class A/1 (Rhodopsin-like rece... 322 | 322
VEGFA-VEGFR2 Pathway 322 | 322
FCERI mediated MAPK activation 317 | 317
Signaling by Insulin receptor 313 | 313
Antigen processing: Ubiquitina... 302 | 302
Extracellular matrix organizat... 292 | 292
Signaling by Type 1 Insulin-li... 291 | 291
Signaling by Wnt 291 | 291
IGF1R signaling cascade 290 | 290
IRS-related events triggered b... 290 | 290
Insulin receptor signalling ca... 289 | 289
Metabolism of carbohydrates 288 | 288
DNA Repair 286 | 286
IRS-mediated signalling 286 | 286
MAPK family signaling cascades 284 | 284
Signaling by the B Cell Recept... 283 | 283
Asparagine N-linked glycosylat... 282 | 282
SLC-mediated transmembrane tra... 280 | 280
Deubiquitination 278 | 278
Interferon Signaling 275 | 275
Platelet activation, signaling... 274 | 274
NCAM signaling for neurite out... 269 | 269
M Phase 267 | 267
Interleukin-3, 5 and GM-CSF si... 263 | 263
RET signaling 262 | 262
Signalling to ERKs 255 | 255
Interleukin-2 signaling 254 | 254
Immunoregulatory interactions ... 252 | 252
VEGFR2 mediated cell prolifera... 250 | 250
RHO GTPase Effectors 249 | 249
Signalling to RAS 248 | 248
Interleukin receptor SHC signa... 247 | 247
G alpha (i) signalling events 245 | 245
Signaling by Leptin 245 | 245
Fatty acid, triacylglycerol, a... 244 | 244
Prolonged ERK activation event... 244 | 244
MAPK1/MAPK3 signaling 243 | 243
Frs2-mediated activation 242 | 242
HIV Infection 242 | 242
ARMS-mediated activation 241 | 241
Signalling to p38 via RIT and ... 241 | 241
Chromatin modifying enzymes 237 | 237
Chromatin organization 237 | 237
GRB2 events in EGFR signaling 237 | 237
RAF/MAP kinase cascade 237 | 237
SHC1 events in EGFR signaling 237 | 237
SOS-mediated signalling 237 | 237
Processing of Capped Intron-Co... 235 | 235
Biological oxidations 215 | 215
Keratinization 213 | 213
Transmission across Chemical S... 210 | 210
rRNA processing 209 | 209
Ion channel transport 204 | 204
Ub-specific processing proteas... 203 | 203

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Metallothionein-2 MT2A Tbio Non-IDG -2.42641 259.2 92
Metallothionein-1G MT1G Tbio Non-IDG -1.33394 21.9 13
Metallothionein-1A MT1A Tbio Non-IDG -1.98676 95.9 34
Metallothionein-1F MT1F Tbio Non-IDG -1.15500 14.0 4
Metallothionein-1E MT1E Tbio Non-IDG -1.58837 40.1 28
Metallothionein-3 MT3 Tbio Non-IDG -2.28869 191.8 79
Metallothionein-1X MT1X Tbio Non-IDG -1.30611 19.5 14
Metallothionein-4 MT4 Tbio Non-IDG -1.55675 34.9 4
Metallothionein-1H MT1H Tbio Non-IDG 29.2 4
Metallothionein-1M MT1M Tdark Non-IDG -1.15497 13.6 4